LuCID Clinical Trial - Owlstone Medical · lucid clinical trial early detection of lung cancer this...

2
limonene isoprene methanol acetonitrile acetone acetamide 2-butanone acetophenone "OWLSTONE MEDICAL HAS DEVELOPED THE BREATH BIOPSY PLATFORM WHICH ENABLES RELIABLE COLLECTION AND ANALYSIS OF VOLATILE ORGANIC COMPOUNDS IN BREATH" LuCID Clinical Trial Early Detection of Lung Cancer THIS YEAR 2.5 Billion WILL COST THE NATIONAL HEALTH SERVICE LUNG CANCER THIS YEAR 44 , 000 PEOPLE WILL BE 35 , 200 WILL DIE IN THE UK LUNG CANCER AND DIAGNOSED WITH NHS IF DETECTED AT STAGE IV STAGE I 75 PEOPLE WILL SURVIVE LUNG CANCER 5 OUT OF 100 UNFORTUNATELY PATIENTS 14.5 % ONLY OF ARE DETECTED AT STAGE I THERE IS AN URGENT AND GROWING NEED TO IMPROVE EARLY DIAGNOSIS IN LUNG CANCER EVERY TIME WE BREATHE OUT THERE OVER A THOUSAND OF CHEMICALS ON OUR BREATH SOME OF THESE CHEMICALS ARE TELL TALE’ MARKERS OF DISEASE 20 2 9 14 21 13 12 19 10 11 8 1 16 18 7 6 17 5 25 26 24 23 22 15 4 3 OUR MISSION 100,000 AND SAVE 1.5 $ BILLION TO SAVE LIVES HEALTHCARE COSTS THE BREATH BIOPSY PLATFORM IS BEING USED IN THE WORLD'S LARGEST BREATH- BASED CLINICAL TRIALS THE LuCID TRIAL WILL RECRUIT UP TO 4,000 PATIENTS ACROSS MULTIPLE CLINICAL SITES IN EUROPE, AND IS EVALUATING THE UTILITY OF BREATH BIOMARKERS IN DETECTION OF LUNG CANCER QUICK, NON-INVASIVE AND EASY TO USE, IT CAN BE USED IN A DOCTOR’S OFFICE TO HELP DETERMINE IF HIGH RISK PATIENTS SHOULD BE REFERRED FOR TESTING IN HOSPITAL

Transcript of LuCID Clinical Trial - Owlstone Medical · lucid clinical trial early detection of lung cancer this...

Page 1: LuCID Clinical Trial - Owlstone Medical · lucid clinical trial early detection of lung cancer this year 2.5 billion will cost the national health service lung cancer this year 44,000

limonene

isoprene

methanolacetonitrile

acetone

acetamide

2-butanone

acetophenone

"OWLSTONE MEDICAL HAS DEVELOPED THE BREATH BIOPSY PLATFORM WHICH ENABLES RELIABLE COLLECTION AND ANALYSIS OF VOLATILE ORGANIC COMPOUNDS IN BREATH"

LuCID Clinical TrialEarly Detection of Lung Cancer

THIS YEAR

2.5Billion

WILL COST THENATIONALHEALTHSERVICE

LUNGCANCER

THIS YEAR44,000PEOPLE WILL BE

35,200WILL DIE IN THE UK

LUNG CANCER ANDDIAGNOSED WITH

NHS

IF DETECTED AT STAGE IVSTAGE I

75PEOPLE WILLSURVIVELUNG CANCER

5OUT

OF 100

UNFORTUNATELY

PATIENTS

14.5%

ONLY

OF

ARE DETECTED AT STAGE I

THERE IS AN URGENT AND GROWING NEED

TO IMPROVE EARLY DIAGNOSISIN LUNG CANCER

EVERY TIME WE BREATHE OUTTHERE OVER A THOUSAND OF

CHEMICALS ON OUR BREATH

SOME OF THESE CHEMICALS ARE‘TELL TALE’ MARKERS OF DISEASE

20

2

9

14

21

13

1219

10

11

8

1

1618

76

17

5

25

26

24

23

2215

43

OUR

MISSION100,000AND SAVE

1.5$ BILLION

TO SAVE

LIVES HEALTHCARE COSTS

THE BREATH BIOPSYPLATFORM IS BEING USED INTHE WORLD'S LARGEST BREATH-

BASED CLINICAL TRIALSTHE LuCID TRIAL WILL RECRUIT UP TO

4,000 PATIENTS ACROSS MULTIPLECLINICAL SITES IN EUROPE, AND ISEVALUATING THE UTILITY OF BREATH

BIOMARKERS IN DETECTION OF

LUNG CANCER

QUICK, NON-INVASIVE AND EASY TO USE,IT CAN BE USED IN A DOCTOR’S OFFICETO HELP DETERMINE IF HIGH RISKPATIENTS SHOULD BE REFERRED FOR

TESTING IN HOSPITAL

Page 2: LuCID Clinical Trial - Owlstone Medical · lucid clinical trial early detection of lung cancer this year 2.5 billion will cost the national health service lung cancer this year 44,000

The LuCID Trial

How Does Breath Biopsy Work?

owlstonemedical.com/lucidOwlstone Medical Ltd, 183 Cambridge Science Park, Milton Road, Cambridge, CB4 0GJ, UK

Company Number 04955647 | VAT Number 260449214

Owlstone Medical's Products and Services are for research use only.Not for use in diagnostic procedures. O

W-0

1734

5-M

C-v

2.0

-01/

2019

50

00 2 4 6 8 10 12

100

150

200

250

300

Fre

que

ncy

Signal

THRESHOLD

CONTROL DISEASE

1 minSample whole body

10 minsCapture even low levelVOC biomarkers

=1 complete

blood circulation

1 min

SCREENING

THE CHEMICAL MARKERS OF LUNG CANCER ARE PRESENT EVEN IN THE EARLIEST STAGES OF THE DISEASE. FOR THE FIRST TIME THERE IS THE REAL POTENTIAL FOR ROUTINE SCREENING AND IMPROVED RATES OF EARLY DIAGNOSIS, TRANSFORMING THE LIVES OF COUNTLESS PATIENTS AND THEIR FAMILIES.

Rapid transfer of VOCsfrom blood to breath

Collect and pre-concentrate VOCs in Breath Biopsy Cartridges

EVERY MINUTE , ALL THEBLOOD IN YOUR BODY PASSESTHROUGH YOUR LUNGS

THIS ALLOWS SAMPLING OFTHE ENTIRE BLOOD VOLUMEIN YOUR BODY

VOLATILE ORGANIC COMPOUNDSFROM YOUR WHOLE BODY CANTHEREFORE BE COLLECTED ANDANALYZED, PROVIDING BOTH LOCALAND SYSTEMIC DISEASE INFORMATION

PATIENTS WITH SUSPECTEDLUNG CANCER GIVE A SAMPLEAT THE SAME TIME AS THEIRHOSPITAL APPOINTMENT

WITH OWLSTONE MEDICAL'SMACHINE LEARNINGALGORITHMS AND BREATH BIOPSY

DIGITAL BIOBANK

ALL PATIENTS HAVE TO DOIS BREATHE THROUGHTHE ReCIVA BREATH SAMPLER

FOR 10 MINUTES

BREATH BIOPSYSAMPLES ARE SENT FOR

ANALYSISIN OWLSTONE MEDICAL’SBREATH BIOPSY LAB

DATA ANALYSIS